Clinical Trials Logo

Clinical Trial Summary

In this project, we plan to evaluate whether a new, rotational thromboelastometry-guided algorithm (ROTEM) to guide hemostatic resuscitation decreases the use of allogeneic blood products, the total amount of bleeding, transfusion related side effects, thromboembolic complications and costs. Its effect on each patient's post-operative hemostatic profile is also measured. We plan to enroll 140 patients having ACLF with variceal bleeding randomized into two groups: one will be treated conventionally using clinical judgement and standard coagulation tests such as prothrombin time, platelet count, etc. the other treated using a ROTEM-based algorithm. They will be followed for development of rebleeding, complications of transfusion and any signs of infection after hospitalization

Clinical Trial Description

Patients with acute-on-chronic liver failure (ACLF) have coagulation failure in the setting of systemic inflammatory syndrome (SIRS), sepsis and extra-hepatic organ failures. The utility of thromboelastography/thromboelastometry currently has unvalidated clinical benefit in the assessment and reversal of coagulopathy among cirrhotic patients as compared to standard coagulation testing.Need for periprocedural blood transfusion is still high in patients with decompensated cirrhosis or ACLF who present with major bleeding. Allogeneic blood transfusion may be detrimental in patients with cirrhosis, due to volume overload and acute lung injury. Viscoelastic testing of global coagulation such as thromboelastometry has been proposed as a superior tool to rapidly diagnose and help guide resuscitation with blood products. In prior studies, we have clarified the pathophysiology of hemostasis in relation to the evidence of sepsis in liver disease and described the accuracy of various available laboratory tests in assessment of these patients. We have described the role of endogenous heparinoids in severe alcoholic hepatitis and the pathogenesis of the coagulation defect in ACLF. We determined the influence of sepsis on coagulation disorders in ACLF patients, to correctly identify the type and optimal quantity of blood product requirement in at risk patients. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05124041
Study type Interventional
Source Postgraduate Institute of Medical Education and Research
Status Recruiting
Phase N/A
Start date November 15, 2021
Completion date May 15, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04604860 - Use of EL-FIT App to Promote Physical Activity N/A
Active, not recruiting NCT01438970 - Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function Phase 2
Recruiting NCT04581369 - Cirrhosis Medical Home N/A
Recruiting NCT04244877 - Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility Phase 3
Recruiting NCT04588077 - Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis Phase 4
Recruiting NCT04082780 - Rifamycin in Minimal Hepatic Encephalopathy Phase 2
Recruiting NCT03850977 - Is There an Association Between Chronic Pancreatitis and Pulmonary Function
Recruiting NCT05093218 - Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease. N/A
Recruiting NCT03437876 - Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced Cirrhosis N/A
Recruiting NCT04643795 - Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects Phase 1
Active, not recruiting NCT02344680 - Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Recruiting NCT04121520 - Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey
Not yet recruiting NCT04591522 - Fecal Microbiota Transplantation in Cirrhosis N/A
Withdrawn NCT03309592 - Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension Phase 4
Active, not recruiting NCT03969186 - Telehealth Intervention in Cirrhotics N/A
Enrolling by invitation NCT04178096 - Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care N/A
Recruiting NCT04221347 - Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC
Recruiting NCT04195724 - Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis N/A
Not yet recruiting NCT04953143 - LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver Disease N/A
Not yet recruiting NCT04592744 - Angiotensin 2 for AKI After OLT Phase 4